Haitao Ji

Haitao Ji

Auto-generated profile, based on publicly available information

Haitao Ji

Drug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9497, United States

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2000 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
HJHaitao Ji
Haitao Ji
WZWannian Zhang
Wannian Zhang
YZYoujun Zhou
Youjun Zhou
MZMin Zhang
Min Zhang
JZJie Zhu
Jie Zhu
JZJü Zhu
Jü Zhu

22 March 2006 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CSChunquan Sheng
Chunquan Sheng
WZWannian Zhang
Wannian Zhang
HJHaitao Ji
Haitao Ji
MZMin Zhang
Min Zhang
YSYunlong Song
Yunlong Song
JLJiaguo Lü
Jiaguo Lü

1 June 2014 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Open access
WGWenxing Guo
Wenxing Guo
JWJohn A. Wisniewski
John A. Wisniewski
HJHaitao Ji
Haitao Ji
Protein-protein interactions (PPIs) are important targets for the development of chemical probes and therapeutic agents. From the initial discovery of the existence of hot spots at PPI interfaces, it has been proposed that hot spots might provide the key for developing small-molecule PPI inhibitors. However, there has been no review on the ways in which the knowledge of hot spots can be used to achieve inhibitor design, nor critical examination of successful examples. This Digest discusses the characteristics of hot spots and the identification of druggable hot spot pockets. An analysis of four examples of hot spot-based design reveals the importance of this strategy in discovering potent and selective PPI inhibitors. A general procedure for hot spot-based design of PPI inhibitors is outlined.

21 January 2021 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
ZWZhen Wang
Zhen Wang
ZLZilu Li
Zilu Li
HJHaitao Ji
Haitao Ji

1 August 2009 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
CSChunquan Sheng
Chunquan Sheng
ZMZhenyuan Miao
Zhenyuan Miao
HJHaitao Ji
Haitao Ji
JYJianzhong Yao
Jianzhong Yao
WWWenya Wang
Wenya Wang
WZWannian Zhang
Wannian Zhang
Cryptococcus neoformans is one of the most important causes of life-threatening fungal infections in immunocompromised patients. Lanosterol 14α-demethylase (CYP51) is the target of azole antifungal agents. This study describes, for the first time, the 3-dimensional model of CYP51 from Cryptococcus neoformans (CnCYP51). The model was further refined by energy minimization and molecular-dynamics simulations. The active site of CnCYP51 was well characterized by multiple-copy simultaneous-search calculations, and four functional regions important for rational drug design were identified. The mode of binding of the natural substrate and azole antifungal agents with CnCYP51 was identified by flexible molecular docking. A G484S substitution mechanism for azole resistance in CnCYP51, which might be important for the conformation of the heme environment, is suggested.

7 December 2015 in Chemical Science
Verified
Journal Article
Open access
PDF file
YZYongqiang Zhang
Yongqiang Zhang
KTKevin B. Teuscher
Kevin B. Teuscher
HJHaitao Ji
Haitao Ji
A photoredox reaction for cross-dehydrogenative coupling (CDC) was developed to Cα-arylate amides (α to nitrogen) and ethers using a variety of five- and six-membered electron-deficient heteroarenes. A unique decomposition mechanism of ammonium persulfate enhanced by photoexcited benzaldehydes was revealed. This benzaldehyde-mediated photoredox reaction proceeded smoothly with household 23 W CFL bulbs as the energy source under metal-free conditions, allowing the construction of new Csp2–Csp2 and Csp3–Csp2 bonds and access to important pharmacophores of broad utility using commercially available reagents.